236 related articles for article (PubMed ID: 11522279)
1. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease.
Sabuncu T; Vural H; Harma M; Harma M
Clin Biochem; 2001 Jul; 34(5):407-13. PubMed ID: 11522279
[TBL] [Abstract][Full Text] [Related]
2. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
Enli Y; Fenkci SM; Fenkci V; Oztekin O
Gynecol Endocrinol; 2013 Dec; 29(12):1036-9. PubMed ID: 23961784
[TBL] [Abstract][Full Text] [Related]
3. Increased oxidative stress is associated with insulin resistance and infertility in polycystic ovary syndrome.
Özer A; Bakacak M; Kıran H; Ercan Ö; Köstü B; Kanat-Pektaş M; Kılınç M; Aslan F
Ginekol Pol; 2016; 87(11):733-738. PubMed ID: 27958630
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.
Macut D; Simic T; Lissounov A; Pljesa-Ercegovac M; Bozic I; Djukic T; Bjekic-Macut J; Matic M; Petakov M; Suvakov S; Damjanovic S; Savic-Radojevic A
Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):451-5. PubMed ID: 21667435
[TBL] [Abstract][Full Text] [Related]
5. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study.
Fatima Q; Amin S; Kawa IA; Jeelani H; Manzoor S; Rizvi SM; Rashid F
Diabetes Metab Syndr; 2019; 13(3):1957-1961. PubMed ID: 31235121
[TBL] [Abstract][Full Text] [Related]
7. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
9. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.
Kucukaydın Z; Duran C; Basaran M; Camlica F; Erdem SS; Basaran A; Kutlu O; Burnik FS; Elmas H; Gonen MS
J Endocrinol Invest; 2016 Oct; 39(10):1139-48. PubMed ID: 27300033
[TBL] [Abstract][Full Text] [Related]
10. Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors?
Isık H; Aynıoglu O; Tımur H; Sahbaz A; Harma M; Can M; Guven B; Alptekin H; Kokturk F
J Reprod Immunol; 2016 Aug; 116():98-103. PubMed ID: 27295433
[TBL] [Abstract][Full Text] [Related]
11. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
12. Infertility and the presence of insulin resistance are associated with increased oxidative stress in young, non-obese Turkish women with polycystic ovary syndrome.
Turan V; Sezer ED; Zeybek B; Sendag F
J Pediatr Adolesc Gynecol; 2015 Apr; 28(2):119-23. PubMed ID: 25850594
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and oxidative marker in women with PCOS.
Bannigida DM; Nayak BS; Vijayaraghavan R
Arch Physiol Biochem; 2020 May; 126(2):183-186. PubMed ID: 30450993
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase (GST) polymorphism could be an early marker in the development of polycystic ovary syndrome (PCOS) - an insight from non-obese and non-insulin resistant adolescents.
Savić-Radojević A; Mažibrada I; Djukić T; Stanković ZB; Plješa-Ercegovac M; Sedlecky K; Bjekić-Macut J; Simić T; Mastorakos G; Macut D
Endokrynol Pol; 2018; 69(4):366-374. PubMed ID: 29952411
[TBL] [Abstract][Full Text] [Related]
16. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease.
Fenkci V; Fenkci S; Yilmazer M; Serteser M
Fertil Steril; 2003 Jul; 80(1):123-7. PubMed ID: 12849813
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
[TBL] [Abstract][Full Text] [Related]
19. Role of Oxidative Stress in Obese and Nonobese PCOS Patients.
Uçkan K; Demir H; Turan K; Sarıkaya E; Demir C
Int J Clin Pract; 2022; 2022():4579831. PubMed ID: 35685525
[TBL] [Abstract][Full Text] [Related]
20. Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome.
Kurdoglu Z; Ozkol H; Tuluce Y; Koyuncu I
J Endocrinol Invest; 2012 Mar; 35(3):317-21. PubMed ID: 21521935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
